HomeStock ScreenerDesh Rakshak Aushdhalaya

Desh Rakshak Aushdhalaya Share Price | Desh Rakshak Aushdhalaya Stock Screener

DESHRAK Pharmaceuticals
Track Desh Rakshak Aushdhalaya share price live with TickJournal's free stock screener. Check DESHRAK 52-week performance for the annual price range and momentum. Use the Desh Rakshak Aushdhalaya stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Desh Rakshak Aushdhalaya Market Cap ₹14.80 Cr.
DESHRAK P/E Ratio (TTM) 23.67
Desh Rakshak Aushdhalaya P/B Ratio 1.18
EPS (TTM) ₹1.07
Dividend Yield -
Debt to Equity 0.30
DESHRAK 52 Week High -
Desh Rakshak Aushdhalaya 52 Week Low -
Operating Margin 22.00%
Profit Margin 12.50%
DESHRAK Revenue (TTM) ₹8.00
EBITDA ₹2.00
Net Income ₹1.00
Total Assets ₹18.00
Total Equity ₹10.00

Desh Rakshak Aushdhalaya Share Price Chart

Screen Desh Rakshak Aushdhalaya share price with an interactive chart. Analyse DESHRAK price trends and volatility across different timeframes.

Desh Rakshak Aushdhalaya Company Profile - Fundamental Screener

Screen Desh Rakshak Aushdhalaya company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DESHRAK shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE971E01016

Desh Rakshak Aushdhalaya Balance Sheet Screener

Screen DESHRAK balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 18 16 16 16 15 12 11 11 10 10
Current Assets 8 6 5 6 6 4 4 4 4 4
Fixed Assets 8 8 8 8 7 5 4 4 4 4
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 3 3 4 4 3 2 1 1 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 10 10 9 9 9 8 8 8 7 7
Share Capital 5 5 5 5 5 5 5 5 5 5
Reserves & Surplus 5 5 5 5 4 4 3 3 3 3

Desh Rakshak Aushdhalaya Income Statement Screener - Profit & Revenue Analysis

Screen Desh Rakshak Aushdhalaya income statement and profit fundamentals. Analyze DESHRAK quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Desh Rakshak Aushdhalaya share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 8 6 6 6 6 7 5 6 5 5 5 5
Expenses 6 5 5 5 5 6 4 5 4 4 4 4
EBITDA 2 1 1 1 1 1 1 1 1 1 1 1
Operating Profit % 22.00% 20.00% 21.00% 21.00% 19.00% 14.00% 15.00% 14.00% 14.00% 13.00% 14.00% 14.00%
Depreciation 1 0 0 0 0 0 0 0 0 0 0 1
Interest 1 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 1 1 1 1 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 1 0 0 1 0 0 0 0 0 0 0
EPS 1.30 1.07 0.96 0.91 1.08 0.95 0.69 0.76 0.64 0.63 0.00 0.05

Desh Rakshak Aushdhalaya Cash Flow Screener - Liquidity Fundamentals

Screen DESHRAK cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 0 2 0 0 1 1 -1 0 0 1
Investing Activities 0 0 -1 -2 -1 -1 0 0 -1 -1
Financing Activities 0 -1 0 1 1 1 0 0 0 0
Net Cash Flow 0 0 0 0 0 0 0 0 -1 1

Desh Rakshak Aushdhalaya Shareholding Pattern Screener

See Desh Rakshak Aushdhalaya shareholding pattern with promoter, FII, and DII holdings. Check Desh Rakshak Aushdhalaya promoter holding and ownership changes for DESHRAK on TickJournal.
Item 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun
Promoter Holding 50.03% 50.03% 50.07% 50.07% 64.28% 64.28% 64.28% 64.28%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 49.83% 49.84% 49.84% 49.84% 35.64% 35.65% 35.65% 35.65%
Other Holding 0.14% 0.14% 0.09% 0.09% 0.07% 0.06% 0.06% 0.06%
Shareholder Count 2,393 2,411 2,429 2,428 2,353 2,345 2,349 2,351

Desh Rakshak Aushdhalaya Share Dividend Screener - Share Yield Analysis

Check Desh Rakshak Aushdhalaya dividend history with payout and yield data. View Desh Rakshak Aushdhalaya dividend details including ex-dates and amounts for DESHRAK stock.
No dividends declared by Desh Rakshak Aushdhalaya.

Desh Rakshak Aushdhalaya Stock Index Membership

See which indices include Desh Rakshak Aushdhalaya stock. Check DESHRAK index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Desh Rakshak Aushdhalaya is not part of any tracked indices.
Only major market indices are tracked in our system.

Desh Rakshak Aushdhalaya Market Events Screener - Corporate Actions

Get Desh Rakshak Aushdhalaya corporate actions including splits, bonuses, and buybacks. Check Desh Rakshak Aushdhalaya stock events that may affect DESHRAK share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 0.00%
2026-12-30 2026-12-30 Annual General Meeting NA -9.09%
2026-02-13 2026-02-13 Quarterly Result Announcement NA -9.52%
2025-12-06 2025-12-06 Quarterly Result Announcement NA -4.86%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 4.75%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -3.95%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -1.99%
2025-05-29 2025-05-29 Extraordinary General Meeting NA 12.83%
2025-02-13 2025-02-13 Quarterly Result Announcement NA 27.53%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 0.00%

Desh Rakshak Aushdhalaya Competitors Screener - Peer Comparison

Screen DESHRAK competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 450,643 40.81 54,729 9.71% 10,980 64.89
Divis Laboratories 179,470 74.13 9,712 18.67% 2,191 64.06
Torrent Pharmaceuticals 149,109 65.68 11,539 6.99% 1,911 58.52
Cipla 115,682 30.09 27,712 -2.46% 3,783 69.78
Dr Reddys Laboratories 111,567 26.16 33,593 -0.44% 3,998 59.87
Lupin 104,032 19.28 27,488 19.98% 5,345 46.11
Mankind Pharma 103,325 56.36 12,744 20.90% 2,007 73.37
Zydus Life Science 101,801 19.85 23,511 18.55% 4,615 69.47
Aurobindo Pharma 87,806 25.16 32,346 9.43% 3,484 73.83
Laurus Labs 71,455 79.78 6,813 21.03% 884 80.26

Desh Rakshak Aushdhalaya Company Announcements - News Screener

Screen DESHRAK latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-29 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-29 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-15 Intimation Pursuant To Regulation 30 Read With Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-04-15 Announcement under Regulation 30 (LODR)-Change in RTA -
2026-04-15 Intimation Pursuant To Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-04-15 Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday 15Th Day Of April 2026 Meeting Commenced At 11:00 A.M. And Concluded At 12:30 P.M Pursuant To Para A Of Part A Of Schedule III And Regulation 30 Of The SEBI (LODR) Reg 2015 -
2026-04-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-09 Board Meeting Intimation for Pre Intimation Of The Board Meeting As Per Regulation 29 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 And Closure Of Trading Window -
2026-04-06 Disclosure Under Sub-Regulation (4) And (5) Of Regulation 31 Of The Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 -
2026-03-27 Closure of Trading Window -
2026-02-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-13 Statement Of No Deviation(S) Or Variation(S) In The Use Of Proceeds And Utilization Of Funds Relating To Allotment Of Equity Shares On Preferential Basis Under Regulation 32 Of The SEBI (LODR) Regulations 2015 -
2026-02-13 Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025 As Per Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-02-13 Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 13Th Day Of February 2026 Meeting Commenced At 01:00 P.M. And Concluded At 02:00 P.M Pursuant To Para A Of Part A Of Schedule III And Regulation 30 Of The SEBI (LODR) Regulations 2015 -
2026-02-09 Board Meeting Intimation for Pre Intimation Of The Board Meeting As Per Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Reg 2015 -
2026-01-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-01-12 Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-01-10 Submission Of Revised Disclosure Under Regulation 29(1) Of The Securities And Exchange Board Of India (SEBI) (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 -
2025-12-31 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-12-31 Intimation Pursuant To Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 -